Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Point72 Asset Management, L.P. Holds 5.6% Passive Stake In Vistagen Therapeutics - 13G Filing

Author: Benzinga Newsdesk | October 05, 2023 04:52pm

https://www.sec.gov/Archives/edgar/data/1411685/000090266423005016/p23-2550sc13g.htm

Posted In: VTGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist